Ardent Health, Inc. reports developments for a healthcare provider serving growing mid-sized urban communities in the United States. Through its subsidiaries, the company operates acute care hospitals and other sites of care across six states, with recurring updates centered on patient volume, admissions, net patient service revenue, adjusted EBITDA, cash flow, guidance, and balance-sheet priorities.
Company news also covers management presentations at healthcare investor conferences, operational-efficiency initiatives such as the IMPACT program, payer and Exchange market dynamics, and technology investments in virtual care. Recent operating updates include enterprise use of AI-assisted virtual nursing, patient observation, and patient-safety monitoring to support clinical workflows across inpatient settings.
Ardent Health (NYSE: ARDT) signed a definitive agreement for The University of Kansas Health System to acquire full ownership of St. Francis Campus. The transaction includes affiliated care locations in Topeka and follows a joint venture partnership of nearly 10 years.
Operational responsibilities and clinical functions previously managed by Ardent will transfer to The University of Kansas Health System. Ardent will continue supporting daily campus operations during the transition, including existing projects. Both organizations expect completion by the end of 2026, subject to necessary approvals and customary closing conditions.
Ardent Health (ARDT) reported that 13 hospitals in its network were recognized in U.S. News & World Report’s 2026-2027 Best Hospitals rankings for performance in specialties, procedures and conditions.
The recognitions include a Best Regional Hospital designation for Lovelace Medical Center, which ranked No. 2 in New Mexico and the Albuquerque metro area, and a No. 19 national ranking for the Oklahoma Heart Institute TAVR program, which is also No. 1 in Oklahoma. Across the system, Ardent hospitals received 34 High Performing ratings in areas such as heart procedures, back surgery, cancer care, joint replacement and rehabilitation.
HealthStream (HSTM) launched the Enterprise Clinical Workforce Platform (ECWP) on September 14, 2026, defining it as a third core enterprise system for health systems alongside the EHR and ERP.
The ECWP, delivered through HealthStream’s hStream platform, is built on a single verified record for every clinician and is positioned to manage the entire clinical workforce lifecycle. HealthStream has also created an ECWP Innovation Partners Program, with Ardent Health (ARDT) joining as an early collaborator to provide feedback and share workforce priorities.
The platform is framed as a strategic C‑suite partnership that can consolidate point solutions, automate compliance and readiness, support nurse development via the AI‑powered Jane solution, and integrate with existing EHR and ERP systems.
Ardent Health (ARDT) highlighted expanded specialty care within the new UT Tyler School of Medicine Building in Tyler, Texas.
UT Health East Texas now offers women's health, pulmonary, orthopedic, imaging and surgical services alongside the region's first medical school, integrating patient care and physician training in a single hub. Since forming a joint venture with The University of Texas System in 2018, Ardent has invested over $315 million, grown its employed and affiliated provider network to about 640 providers (a 116% increase), and supported expansion of graduate medical education from about 39 residents to more than 270, with approval to grow to 323. Multiple facilities have earned recurring “A” Safety Grades and Top Hospital recognition from The Leapfrog Group.
Ardent Health (NYSE: ARDT) announced it will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston, Massachusetts, on Wednesday, September 9, 2026. Management will host a fireside chat at 11 a.m. ET, with a live webcast and replay available on the company’s investor relations website.
Ardent Health (NYSE: ARDT), through Oklahoma Heart Institute (OHI), reports that OHI is the only site in Oklahoma and the surrounding region participating in several major national cardiovascular trials and is the first U.S. center to use the next-generation Supira percutaneous left ventricular assist device (pVAD) in the SUPPORT II clinical trial.
According to Ardent Health, OHI is evaluating emerging technologies for complex structural heart disease, including participation in the STAR Trial for a next-generation transcatheter aortic valve replacement (TAVR) system. OHI also served as the leading global enroller in the ENCIRCLE Trial, which supported FDA approval of the Edwards SAPIEN M3 transcatheter mitral valve replacement system in 2025. OHI is currently the only provider of this TMVR therapy in Oklahoma, reflecting Ardent Health’s strategy of expanding access to advanced, minimally invasive cardiovascular treatments through physician-led research and investment.
Ardent Health (NYSE: ARDT) reported second quarter 2026 revenue of $1.622 billion, down 1.4% year-over-year, with net income attributable to Ardent Health of $17 million ($0.12 per diluted share) versus $73 million ($0.52) a year earlier. Adjusted EBITDA declined 32.3% to $115 million, and net patient service revenue per adjusted admission fell 3.9%.
Adjusted admissions grew 2.5%, while admissions decreased 1.0% and total surgeries declined 2.9%. Operating cash flow rose 67% to $197 million. As of June 30, 2026, Ardent held $724 million in cash, $1.1 billion of total debt, net leverage of 0.8x, and available liquidity of $992 million. The company repurchased 1.4 million shares for $13 million, with $34 million remaining under its authorization.
Ardent reaffirmed full-year 2026 total revenue guidance of $6.4–$6.7 billion and Adjusted EBITDA guidance of $485–$535 million, while reducing net income and diluted EPS ranges. According to Ardent Health, its IMPACT program is now expected to generate at least $70 million of savings in 2026, up from $55 million previously.
Ardent Health (NYSE: ARDT) reported that its physicians and advanced practice providers have surpassed 1 million patient encounters supported by Ambience Healthcare’s ambient AI platform. Ardent-affiliated clinicians now use Ambience in 87% of ambulatory encounters across specialties, compared with industry benchmarks of roughly 40%–45% reported in studies.
According to Ardent Health, EHR data show providers save on average more than three hours per week on documentation. Since the enterprise-wide deployment in September 2025, Ambience has supported over 418,000 unique patients across Ardent’s ambulatory network, reflecting deeper integration of ambient AI into daily clinical workflows.
Ardent Health (NYSE: ARDT) will release its second quarter 2026 results after market close on Tuesday, August 4, 2026. A results conference call and webcast will follow on Wednesday, August 5, 2026 at 10 a.m. ET, accessible via the Investor Relations section at ir.ardenthealth.com. Live teleconference access is available at 1-888-596-4144 (North America toll-free) or 1-646-968-2525 (international), using access code 4437657. A replay will be available through August 19, 2026 at 1-800-770-2030 (North America toll-free) or 1-647-362-9199 (international), with the same access code.
Ardent Health (NYSE: ARDT) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, Florida, on June 10, 2026. Management will join a fireside chat at 11:20 a.m. ET, with a live audio webcast and replay available on the company’s investor relations website.